I have a couple of patients right now receiving cemiplimab for met SCC. One is s/p renal transplant many many years ago, the other is not a transplant pt. Both pts are doing extremely well. One is having a fabulous response, with ongoing excellent renal function (better than when he started Rx in fact) and no sign of rejection thus far. The other has not yet been restaged, but is using much less opioid analgesia for related pain. That is a good sign. Too early to tell, but as we all gain more and more experience, it is great to share.